Literature DB >> 12215438

Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework.

Adrian Auf der Maur1, Christian Zahnd, Franziska Fischer, Silvia Spinelli, Annemarie Honegger, Christian Cambillau, Dominik Escher, Andreas Plückthun, Alcide Barberis.   

Abstract

Single-chain Fv antibody fragments (scFv) represent a convenient antibody format for intracellular expression in eukaryotic or prokaryotic cells. These so-called intrabodies have great potential in functional genomics as a tool to study the function of newly identified proteins in vivo, for example by binding-induced modulation of their activity or by blocking interactions with other proteins. However, the intracellular expression and activity of many single-chain Fvs are limited by their instability and folding efficiency in the reducing intracellular environment, where the highly conserved intrachain disulfide bonds do not form. In the present work, we used an in vivo selection system to isolate novel antigen-binding intrabodies. We screened two intrabody libraries carrying a randomized third hypervariable loop onto the heavy chain of a stable framework, which had been further optimized by random mutagenesis for better behavior in the selection system, and we biophysically characterized the selected variants to interpret the outcome of the selection. Our results show that single-framework intrabody libraries can be directly screened in vivo to rapidly select antigen-specific intrabodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215438     DOI: 10.1074/jbc.M205264200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Research and development of next generation of antibody-based therapeutics.

Authors:  Jing Li; Zhenping Zhu
Journal:  Acta Pharmacol Sin       Date:  2010-08-09       Impact factor: 6.150

2.  Understanding differences between synthetic and natural antibodies can help improve antibody engineering.

Authors:  Anat Burkovitz; Yanay Ofran
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

3.  Versatile selection technology for intracellular protein-protein interactions mediated by a unique bacterial hitchhiker transport mechanism.

Authors:  Dujduan Waraho; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

4.  Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Authors:  D C Stylianou; A Auf der Maur; D P Kodack; R T Henke; S Hohn; J A Toretsky; A T Riegel; A Wellstein
Journal:  Oncogene       Date:  2009-07-27       Impact factor: 9.867

5.  Intrabody expression in eukaryotic cells.

Authors:  Laurence Guglielmi; Pierre Martineau
Journal:  Methods Mol Biol       Date:  2009

6.  A strategy for adenovirus vector targeting with a secreted single chain antibody.

Authors:  Joel N Glasgow; Galina Mikheeva; Victor Krasnykh; David T Curiel
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

7.  Optimizing recombinant antibodies for intracellular function using hitchhiker-mediated survival selection.

Authors:  Dujduan Waraho-Zhmayev; Bunyarit Meksiriporn; Alyse D Portnoff; Matthew P DeLisa
Journal:  Protein Eng Des Sel       Date:  2014-09-14       Impact factor: 1.650

8.  Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity.

Authors:  Liang Li; Christopher S Gondi; Dzung H Dinh; William C Olivero; Meena Gujrati; Jasti S Rao
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

9.  Engineering antibody fragments to fold in the absence of disulfide bonds.

Authors:  Min Jeong Seo; Ki Jun Jeong; Clinton E Leysath; Andrew D Ellington; Brent L Iverson; George Georgiou
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  A step ahead: combining protein purification and correct folding selection.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2004-10-07       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.